Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database

Publication Details

Journal
Acceda (Universidad de Las Palmas de Gran Canaria)
Published
2025-01-01
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database

Acceda (Universidad de Las Palmas de Gran Canaria)
Inflammatory Bowel Disease
article

Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database

article en

Abstract

No abstract available for this paper.
Acceda (Universidad de Las Palmas de Gran Canaria)
Zero hunger
Openalex Percentile: Top 39%
Inflammatory Bowel Disease
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database · Acceda (Universidad de Las Palmas de Gran Canaria) (2025) | TGRS Research Map | TGRS